This bill allows pharmaceutical manufacturers to provide prescription drug information to doctors and pharmacists primarily through digital means rather than requiring paper copies. However, manufacturers must still offer healthcare professionals the option to receive information in paper form or request printed materials at no cost whenever they want. The bill directs the Secretary of Health and Human Services to issue regulations within one year to implement this change and explain how medical professionals can obtain paper copies directly from manufacturers or distributors. The new rules take effect two years after the law passes, or when the final regulations are issued, whichever comes first. Additionally, the FDA must hold a public workshop within two years to gather feedback from stakeholders on how to improve the format, accessibility, and usability of prescription information as it transitions to digital delivery.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.